Intraocular delivery of Avastin using topical ultrasound (proof of principle)

  • De Veer, Michael (Primary Chief Investigator (PCI))
  • Paterson, Brett (Chief Investigator (CI))
  • Sepehrizadeh, Tara (Chief Investigator (CI))

Project: Research

Project Details

Project Description

The study is to determine whether MuPharma’s proprietary ultrasonic delivery device can deliver Avastin antibody to the subsclera tissue layers of the eye. The study will measure where the antibody migrates to within the eye substructures over 3 hours, with a focus on whether the antibody reaches the retina. The imaging is limited to studying both eyes and the head region of each rabbit.
Short titleMuPharma Avastin proof of principle
StatusFinished
Effective start/end date1/06/19 → 1/01/20

Funding

  • MuPharma: A$16,904.00